[Form 4] iREIT MarketVector Quality REIT Index ETF Insider Trading Activity

Rhea-AI Filing Summary

John A. Schissel, identified as a Director of CENTERSPACE (CSR), reported a non-derivative purchase of 500 common shares at $54 per share on 08/08/2025, bringing his direct beneficial ownership to 14,398 shares. The Form 4 lists the transaction code P and shows only non-derivative common shares; no derivative holdings are reported.

Insights

Securities Analyst

TL;DR: Director purchased 500 common shares, raising direct ownership to 14,398; filing reports only non-derivative shares.

The Form 4 discloses a straightforward open-market or plan purchase (transaction code P) of 500 common shares at $54 on 08/08/2025, resulting in 14,398 shares beneficially owned directly. No derivative securities are reported in Table II. The disclosure is routine and, based on the information provided, does not by itself indicate a material event affecting the issuer's capital structure.

Corporate Governance Expert

TL;DR: Insider purchase disclosed; ownership remains direct and the filing was submitted by a single reporting person.

The filing identifies John A. Schissel as a director and records a non-derivative acquisition of 500 common shares at $54, increasing his direct stake to 14,398 shares. The Form 4 shows no joint filers and no derivative positions, and it was executed via an attorney-in-fact. This appears to be a routine Form 4 disclosure consistent with Section 16 reporting requirements.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Schissel John A

(Last) (First) (Middle)

C/O CENTERSPACE

3100 10TH STREET SW

(Street)

MINOT ND 58701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CENTERSPACE [ CSR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares of Beneficial Interest	08/08/2025		P		500	A	$54	14,398	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Bhairav Patel, Attorney in Fact for John Schissel	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did John A. Schissel report on the Form 4 for CENTERSPACE (CSR)?

He acquired 500 common shares at a price of $54 per share on 08/08/2025, raising direct beneficial ownership to 14,398 shares.

What is John A. Schissel's relationship to CENTERSPACE (CSR)?

The Form 4 identifies John A. Schissel as a Director of CENTERSPACE.

Were any derivative securities reported in this Form 4 filing?

No. Table II contains no entries; only non-derivative common shares are reported in Table I.

What transaction code is shown on the Form 4?

The filing shows transaction code P for the reported transaction.

Was the Form 4 filed jointly or by a single reporting person?

The form indicates it was filed by one reporting person.